tradingkey.logo

Zhengye Biotechnology Holding Ltd

ZYBT

5.360USD

+0.060+1.13%
Market hours ETQuotes delayed by 15 min
252.81MMarket Cap
--P/E TTM

Zhengye Biotechnology Holding Ltd

5.360

+0.060+1.13%
More Details of Zhengye Biotechnology Holding Ltd Company
Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
Company Info
Ticker SymbolZYBT
Company nameZhengye Biotechnology Holding Ltd
IPO dateJan 07, 2025
CEOMr. Songlin Song
Number of employees277
Security typeOrdinary Share
Fiscal year-endJan 07
AddressNo.1 Lianmeng Street, Jilin Economic &
CityJILIN
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code132101
Phone
Websitehttps://www.jlzybio.com./
Ticker SymbolZYBT
IPO dateJan 07, 2025
CEOMr. Songlin Song
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Ping Jiang
Mr. Ping Jiang
Independent Director
Independent Director
--
--
Mr. Zhongyao Liu
Mr. Zhongyao Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiayao Wu
Mr. Jiayao Wu
Independent Director
Independent Director
--
--
Mr. Wenbing (Christopher) Wang
Mr. Wenbing (Christopher) Wang
Independent Director
Independent Director
--
--
Mrs. Wenhua Sun
Mrs. Wenhua Sun
Director
Director
--
--
Mr. Ping Wang
Mr. Ping Wang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Yuhong Cheng
Ms. Yuhong Cheng
Vice General Manager
Vice General Manager
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Ping Jiang
Mr. Ping Jiang
Independent Director
Independent Director
--
--
Mr. Zhongyao Liu
Mr. Zhongyao Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiayao Wu
Mr. Jiayao Wu
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Jul 12
Updated: Sat, Jul 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Securingium Holding Ltd
84.40%
Han (Zhenfa)
6.25%
Dong (Yawen)
0.26%
Lian (Wei)
0.18%
He (Yuyou)
0.11%
Other
8.80%
Shareholders
Shareholders
Proportion
Securingium Holding Ltd
84.40%
Han (Zhenfa)
6.25%
Dong (Yawen)
0.26%
Lian (Wei)
0.18%
He (Yuyou)
0.11%
Other
8.80%
Shareholder Types
Shareholders
Proportion
Corporation
84.40%
Individual Investor
6.80%
Investment Advisor
0.08%
Investment Advisor/Hedge Fund
0.02%
Other
8.70%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
10
43.27M
91.30%
+40.30M
2025Q1
9
43.23M
91.66%
+40.26M
2024Q4
1
2.96M
6.28%
+2.96M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Securingium Holding Ltd
40.00M
84.4%
+40.00M
--
Jan 07, 2025
Han (Zhenfa)
2.96M
6.25%
--
--
Jan 07, 2025
Dong (Yawen)
124.59K
0.26%
+124.59K
--
Jan 07, 2025
Lian (Wei)
83.06K
0.18%
+83.06K
--
Jan 07, 2025
He (Yuyou)
50.06K
0.11%
+50.06K
--
Jan 07, 2025
Geode Capital Management, L.L.C.
8.45K
0.02%
--
--
May 31, 2025
UBS Financial Services, Inc.
1.29K
0%
+1.29K
--
Mar 31, 2025
Morgan Stanley & Co. LLC
46.00
0%
+46.00
--
Mar 31, 2025
Tower Research Capital LLC
1.00
0%
+1.00
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco Golden Dragon China ETF
0.16%
Invesco Golden Dragon China ETF
Proportion0.16%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI